Skip to content
Biodatica
Start free

Investigator

Jun Wang

TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · funded by NIDA, NIA, NIOSH

Companies
5

Resolved onto their grants.

Grants
20

Federal awards on file.

Non-dilutive funding
$13M

Summed across those awards.

First award
Sep 25, 2018

Latest Jun 15, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Cholinergic Dysregulation of Cognitive Flexibility in Cocaine Use Disorder

    $675k

    Jun 15, 2026NIDATEXAS A&M UNIVERSITY HEALTH SCIENCE CTRNIH RePORTER · 11455953 (opens the source filing in a new tab)

  2. R21

    Regulatory Landscape of Neurodegeneration by Single-Cell Spatial Multiomics

    $455k

    Feb 15, 2026NIASTATE UNIVERSITY NEW YORK STONY BROOKNIH RePORTER · 11303064 (opens the source filing in a new tab)

  3. RF1

    Promoting stress-resilience prevents AD-associated neuropsychiatric symptoms

    $3.5M

    Sep 1, 2025NIAICAHN SCHOOL OF MEDICINE AT MOUNT SINAINIH RePORTER · 11107369 (opens the source filing in a new tab)

  4. R21

    Human-Robot Collaboration in Construction: Assessing Cognitive Factors for Construction Workers Using Virtual Reality-Wearable Devices-Data Analytics Integrated Approach

    $126k

    Sep 30, 2024NIOSHMISSISSIPPI STATE UNIVERSITYNIH RePORTER · 11196050 (opens the source filing in a new tab)

  5. R01

    Mapping Adolescent Social Media Experiences and Mental Health Across Time, Context, and Race and Ethnicity

    $729k

    Aug 1, 2024NIMHTEXAS A&M AGRILIFE RESEARCHNIH RePORTER · 11140400 (opens the source filing in a new tab)

  6. R01

    Development of point-of-care mobile health technology to reduce heat and pesticides-induced farmworker health disparity

    $527k

    Mar 7, 2024NIBIBUNIVERSITY OF NORTH CAROLINA CHARLOTTENIH RePORTER · 11051782 (opens the source filing in a new tab)

  7. R01

    Development of point-of-care mobile health technology to reduce heat and pesticides-induced farmworker health disparity

    $515k

    Mar 7, 2024NIBIBUNIVERSITY OF NORTH CAROLINA CHARLOTTENIH RePORTER · 11325005 (opens the source filing in a new tab)

  8. R35

    Advanced Single-Cell Protein Analysis with Multiplex in Situ Tagging Array Technology

    $394k

    Feb 1, 2024NIGMSSTATE UNIVERSITY NEW YORK STONY BROOKNIH RePORTER · 11017811 (opens the source filing in a new tab)

  9. R35

    Advanced Single-Cell Protein Analysis with Multiplex in Situ Tagging Array Technology

    $394k

    Feb 1, 2024NIGMSSTATE UNIVERSITY NEW YORK STONY BROOKNIH RePORTER · 11259535 (opens the source filing in a new tab)

  10. R01

    Development of 2C inhibitors as broad-spectrum enterovirus antivirals

    $740k

    Dec 1, 2023NIAIDRUTGERS BIOMEDICAL AND HEALTH SCIENCESNIH RePORTER · 10991356 (opens the source filing in a new tab)

  11. R01

    Development of 2C inhibitors as broad-spectrum enterovirus antivirals

    $768k

    Dec 1, 2023NIAIDRUTGERS BIOMEDICAL AND HEALTH SCIENCESNIH RePORTER · 11257284 (opens the source filing in a new tab)

  12. R01

    Striatal ensemble plasticity in alcohol use disorder

    $471k

    Aug 1, 2023NIAAATEXAS A&M UNIVERSITY HEALTH SCIENCE CTRNIH RePORTER · 11088219 (opens the source filing in a new tab)

  13. R01

    Striatal ensemble plasticity in alcohol use disorder

    $452k

    Aug 1, 2023NIAAATEXAS A&M UNIVERSITY HEALTH SCIENCE CTRNIH RePORTER · 11336789 (opens the source filing in a new tab)

  14. R01

    Elucidating the Immune Suppressive Mechanism of SIGLEC-15 in the Tumor Microenvironment

    $578k

    Dec 1, 2022NCINEW YORK UNIVERSITY SCHOOL OF MEDICINENIH RePORTER · 11231678 (opens the source filing in a new tab)

  15. R37

    Elucidating the Role of Cancer-Associated FGL1 in Tumor Immunity and Developing FGL1-Guided Anti-LAG-3 Cancer Immunotherapy

    $571k

    Jul 11, 2022NCINEW YORK UNIVERSITY SCHOOL OF MEDICINENIH RePORTER · 11126873 (opens the source filing in a new tab)

  16. I01

    Sex-specific role of CCL5/CCR5 axis in depression and its therapeutic implication

    Jul 1, 2022VAJAMES J PETERS VA MEDICAL CENTERNIH RePORTER · 11131026 (opens the source filing in a new tab)

  17. R42

    Development of an integrated smartphone-nanosensor platform for onsite biomonitoring of exposure to pesticides

    $204k

    Feb 28, 2022NIEHSNANODIAGNOSTIC TECHNOLOGY, LLCNIH RePORTER · 11052455 (opens the source filing in a new tab)

  18. R42

    Development of an integrated smartphone-nanosensor platform for onsite biomonitoring of exposure to pesticides

    $695k

    Feb 28, 2022NIEHSNANODIAGNOSTIC TECHNOLOGY, LLCNIH RePORTER · 11327245 (opens the source filing in a new tab)

  19. R01

    Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals

    $714k

    Jan 4, 2022NIAIDRUTGERS BIOMEDICAL AND HEALTH SCIENCESNIH RePORTER · 11316960 (opens the source filing in a new tab)

  20. R01

    Genetic dissection of Cardiac Conduction System homeostasis and Repair

    $615k

    Sep 25, 2018NHLBIUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTONNIH RePORTER · 11237191 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources